Daclatasvir plus sofosbuvir for HCV infection

New England Journal of Medicine

Volumn 370, Issue 16, 2014, Pages 1560-1561

  Dhaliwal, Harpal S ^a   Nampoothiri, Ram V ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

DACLATASVIR; SOFOSBUVIR; VIRUS RNA; INTERFERON; ANTIVIRUS AGENT; DRUG DERIVATIVE; IMIDAZOLE DERIVATIVE; URIDINE PHOSPHATE; VIRUS PROTEIN;

DRUG RESPONSE; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; LETTER; NONHUMAN; PRIORITY JOURNAL; VIRUS INHIBITION; VIRUS LOAD; BLOOD CELL; DRUG USE; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOCOMPROMISED PATIENT; MONONUCLEAR CELL; RECURRENCE RISK; RELAPSE; VIRUS REACTIVATION; VIRUS REPLICATION; DRUG ANTAGONISM; FEMALE; GENETICS; MALE; NOTE;

ANTIVIRAL AGENTS; FEMALE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; IMIDAZOLES; MALE; URIDINE MONOPHOSPHATE; VIRAL NONSTRUCTURAL PROTEINS;

EID: 84898663922     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1401726     Document Type: Letter

References (5)

1. Sulkowski MS, Gardiner DF, Rodriguez-Torres M, et al. Daclatasvir plus sofosbuvir for previously treated or untreated chronic HCV infection. N Engl J Med 2014;370:211-21.
2. Swain MG, Lai MY, Shiffman ML, et al. A sustained virologic response is durable in patients with chronic hepatitis C treated with peginterferon alfa-2a and ribavirin. Gastroenterology 2010;139:1593-601.
3. Martinot-Peignoux M, Stern C, Maylin S, et al. Twelve weeks posttreatment follow-up is as relevant as 24 weeks to determine the sustained virologic response in patients with hepatitis C virus receiving pegylated interferon and ribavirin. Hepatology 2010;51:1122-6.
4. Pham TN, MacParland SA, Mulrooney PM, Cooksley H, Naoumov NV, Michalak TI. Hepatitis C virus persistence after spontaneous or treatment-induced resolution of hepatitis C. J Virol 2004;78:5867-74. (Pubitemid 38661674)
5. Radkowski M, Gallegos-Orozco JF, Jablonska J, et al. Persistence of hepatitis C virus in patients successfully treated for chronic hepatitis C. Hepatology 2005;41:106-14. (Pubitemid 40066388)